Cargando…

Targeting caveolin-1 deficiency in bone marrow derived cells: a new therapeutic window for fibrotic diseases?

Detalles Bibliográficos
Autores principales:	Cianci, Eleonora, Recchiuti, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2014
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4141328/ https://www.ncbi.nlm.nih.gov/pubmed/25202273 http://dx.doi.org/10.3389/fphar.2014.00193

Ejemplares similares

Caveolin-1 regulates chemokine receptor 5-mediated contribution of bone marrow-derived cells to dermal fibrosis
por: Lee, Rebecca, et al.
Publicado: (2014)

Therapeutic Targeting of Fibrotic Epithelial-Mesenchymal Transition–An Outstanding Challenge
por: Fintha, Attila, et al.
Publicado: (2019)

Anti-fibrotic potential of erythropoietin signaling on bone marrow derived fibrotic cell
por: Iwata, Yasunori, et al.
Publicado: (2021)

Caveolin-1 Regulates Cellular Metabolism: A Potential Therapeutic Target in Kidney Disease
por: Luo, Shilu, et al.
Publicado: (2021)

Roles, Actions, and Therapeutic Potential of Specialized Pro-resolving Lipid Mediators for the Treatment of Inflammation in Cystic Fibrosis
por: Recchiuti, Antonio, et al.
Publicado: (2019)

Is There a Potential Therapeutic Role for Caveolin-1 in Fibrosis?
por: Shihata, Waled A., et al.
Publicado: (2017)

Caveolin-1-Related Intervention for Fibrotic Lung Diseases
por: Shetty, Sreerama, et al.
Publicado: (2023)

Astragalus and its formulas as a therapeutic option for fibrotic diseases: Pharmacology and mechanisms
por: Zhu, Yi, et al.
Publicado: (2022)

Bone marrow mesenchymal stromal cell-derived small extracellular vesicles: A novel therapeutic agent in ischemic heart diseases
por: Chang, Wenguang, et al.
Publicado: (2023)

Therapeutic potential of bone marrow mesenchymal stem cells in cyclophosphamide-induced infertility
por: Ibrahim, Dalia, et al.
Publicado: (2023)

Novel Anti-fibrotic Therapies
por: McVicker, Benita L., et al.
Publicado: (2017)

Editorial: New lights Through Old Windows: Metformin and Derivatives as Anti-Cancer Treatments
por: Moldasheva, Aiman, et al.
Publicado: (2022)

The Resolution Approach to Cystic Fibrosis Inflammation
por: Recchiuti, Antonio, et al.
Publicado: (2020)

Are mast cells instrumental for fibrotic diseases?
por: Overed-Sayer, Catherine, et al.
Publicado: (2014)

Pharmacokinetic-Pharmacodynamic Assessment of the Hepatic and Bone Marrow Toxicities of the New Trypanoside Fexinidazole
por: Watson, James A., et al.
Publicado: (2019)

Anti-fibrotic Potential of AT(2) Receptor Agonists
por: Wang, Yan, et al.
Publicado: (2017)

Cell volume restriction by mercury chloride reduces M1-like inflammatory response of bone marrow-derived macrophages
por: Chuang, Yen-Chieh, et al.
Publicado: (2022)

Fibrocytes in the fibrotic lung: altered phenotype detected by flow cytometry
por: Reese, Charles, et al.
Publicado: (2014)

Hepatoprotective and Anti-fibrotic Agents: It's Time to Take the Next Step
por: Weiskirchen, Ralf
Publicado: (2016)

A Clinical Perspective of Anti-Fibrotic Therapies for Cardiovascular Disease
por: Fang, Lu, et al.
Publicado: (2017)

Microvascular Targets for Anti-Fibrotic Therapeutics
por: Pu, Kai-Ming T., et al.
Publicado: (2013)

Relaxin Can Mediate Its Anti-Fibrotic Effects by Targeting the Myofibroblast NLRP3 Inflammasome at the Level of Caspase-1
por: Pinar, Anita A., et al.
Publicado: (2020)

Amygdalin Attenuates Atherosclerosis and Plays an Anti-Inflammatory Role in ApoE Knock-Out Mice and Bone Marrow-Derived Macrophages
por: Wang, Yiru, et al.
Publicado: (2020)

TMT-Based Quantitative Proteomic Analysis Reveals the Effect of Bone Marrow Derived Mesenchymal Stem Cell on Hair Follicle Regeneration
por: Zhang, Chao, et al.
Publicado: (2021)

Corrigendum: Cell volume restriction by mercury chloride reduces M1-like inflammatory response of bone marrow-derived macrophages
por: Chuang, Yen-Chieh, et al.
Publicado: (2023)

Artemisinin and artemisinin derivatives as anti-fibrotic therapeutics
por: Dolivo, David, et al.
Publicado: (2021)

Genetic architecture of human fibrotic diseases: disease risk and disease progression
por: Gardet, Agnès, et al.
Publicado: (2013)

Clinical Review: Navitoclax as a Pro-Apoptotic and Anti-Fibrotic Agent
por: Mohamad Anuar, Nur Najmi, et al.
Publicado: (2020)

Bone marrow stromal cells reduce low-dose cytarabine-induced differentiation of acute myeloid leukemia
por: Smoljo, Tomislav, et al.
Publicado: (2023)

Targeting GIRK Channels for the Development of New Therapeutic Agents
por: Walsh, Kenneth B.
Publicado: (2011)

Epigenetics and Vascular Senescence–Potential New Therapeutic Targets?
por: Ding, Qian, et al.
Publicado: (2020)

Necroptosis in Pulmonary Diseases: A New Therapeutic Target
por: Wang, Lingling, et al.
Publicado: (2021)

Ferroptosis: A new therapeutic target for bladder cancer
por: Zeng, Fan, et al.
Publicado: (2022)

Role of Caveolin-1 in Atrial Fibrillation as an Anti-Fibrotic Signaling Molecule in Human Atrial Fibroblasts
por: Yi, Shao-lei, et al.
Publicado: (2014)

Electronic Cigarette Exposure Enhances Lung Inflammatory and Fibrotic Responses in COPD Mice
por: Han, Hongwei, et al.
Publicado: (2021)

Metabolomic Profiling for Histologically Fibrotic Stage in Chronic Drug-Induced Liver Injury
por: He, Xian, et al.
Publicado: (2022)

Physiologic Consequences of Caveolin-1 Ablation in Conventional Outflow Endothelia
por: De Ieso, Michael L., et al.
Publicado: (2020)

Research trends and hotspots on the links between caveolin and cancer: bibliometric and visual analysis from 2003 to 2022
por: Tan, Yaqian, et al.
Publicado: (2023)

Editorial: Ferroptosis as new therapeutic targets in cancer: From molecular mechanisms to therapeutic opportunities
por: Chen, Jian, et al.
Publicado: (2022)

Impaired anti-fibrotic effect of bone marrow-derived mesenchymal stem cell in a mouse model of pulmonary paracoccidioidomycosis
por: Arango, Julián Camilo, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_l6cn2pjh64ri7u9u9v7jd925ct